Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$394K Buy
1,119
+196
+21% +$69.9K 0.1% 137
2025
Q4
$302K Buy
923
+17
+2% +$5.39K 0.08% 148
2025
Q3
$256K Sell
906
-23
-2% -$6.67K 0.08% 160
2025
Q2
$259K Sell
929
-388
-29% -$110K 0.09% 155
2025
Q1
$410K Buy
1,317
+62
+5% +$18.3K 0.15% 98
2024
Q4
$327K Buy
+1,255
New +$372K 0.13% 107

Other funds holding AMGN

May Hill Capital's AMGN Position: Q1 2026 in Review

May Hill Capital increased its Amgen (AMGN) stake by 21% in Q1 2026, buying an estimated $69.9K and bringing the position to 1,119 shares worth $394K. The position accounts for 0.1% of the portfolio, ranked #137.

May Hill Capital first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $410K in Q1 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • May Hill Capital held 1,119 shares of Amgen worth $394K as of Q1 2026.
  • May Hill Capital bought 196 Amgen shares in Q1 2026, an estimated $69.9K.
  • Amgen made up 0.1% of May Hill Capital's portfolio in Q1 2026, its #137 holding.
  • May Hill Capital first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • May Hill Capital's Amgen position peaked at $410K in Q1 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on May Hill Capital's 13F filing for Q1 2026, filed 6 May 2026.